Отправить статью по E-mail Pharmacopoeial Quality Requirements for Compounded Pharmaceuticals: Present and Future
- Авторы: Shishova L.I.1, Sakanyan E.I.1, Shemeryankina T.B.1, Gubareva O.N.1
-
Учреждения:
- Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
- Выпуск: Том 51, № 8 (2017)
- Страницы: 731-734
- Раздел: Article
- URL: https://journals.rcsi.science/0091-150X/article/view/244778
- DOI: https://doi.org/10.1007/s11094-017-1683-3
- ID: 244778
Цитировать
Открытый доступ
Доступ предоставлен
Только для подписчиков
Аннотация
Issues related to regulation of the quality of compounded medicinal preparations by the State Pharmacopoeia of the Russian Federation are considered. Topical questions of the development and implementation of both general clauses and particular monographs related to compounded pharmaceuticals in national pharmacopoeial science and practice are discussed.
Об авторах
L. Shishova
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Россия, 8/2 Petrovskii Blvd., Moscow, 127051
E. Sakanyan
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Россия, 8/2 Petrovskii Blvd., Moscow, 127051
T. Shemeryankina
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Россия, 8/2 Petrovskii Blvd., Moscow, 127051
O. Gubareva
Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation
Email: chem@folium.ru
Россия, 8/2 Petrovskii Blvd., Moscow, 127051
Дополнительные файлы
